Alpha Tau Medical Ltd.
DRTS
$2.62
-$0.02-0.76%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 2.74M | 2.19M | 2.45M | 2.25M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 10.27M | 9.05M | 9.94M | 8.93M | |
| Operating Income | -10.27M | -9.05M | -9.94M | -8.93M | |
| Income Before Tax | -9.47M | -7.37M | -7.36M | -4.95M | |
| Income Tax Expenses | 2.00K | 3.00K | 8.00K | -39.00K | |
| Earnings from Continuing Operations | -9.48M | -7.37M | -7.37M | -4.91M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -9.48M | -7.37M | -7.37M | -4.91M | |
| EBIT | -10.27M | -9.05M | -9.94M | -8.93M | |
| EBITDA | -10.00M | -8.77M | -9.67M | -8.68M | |
| EPS Basic | -0.14 | -0.11 | -0.11 | -0.07 | |
| Normalized Basic EPS | -0.08 | -0.07 | -0.07 | -- | |
| EPS Diluted | -0.14 | -0.11 | -0.11 | -0.07 | |
| Normalized Diluted EPS | -0.08 | -0.07 | -0.07 | -- | |
| Average Basic Shares Outstanding | 70.14M | 69.87M | 69.57M | 69.42M | |
| Average Diluted Shares Outstanding | 70.14M | 69.87M | 69.57M | 69.42M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |